NCT00555633

Completed

Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Ca...

Medical University of Graz Source

Compare

Other study identifiers

Sponsor study identifier

16-015 ex 04/05

Study Type

observational

Actual enrollment (reported)

13

Locations

1 country

Sites

1

Timeline

Study Start

October 2004

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

February 2006

Actual (reported)

Brief Summary

Study aim: To determine the effect of an intensified daily photoprotection over 24 months with an SPF30 sunscreen and an after sun-lotion both containing liposomal DNA repair enzymes in a population of patients at high-risk for skin cancer, including xeroderma pigmentosum (XP) and basal cell nevus syndrome.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 13 participants
Study completion date: February 2006
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
October 2004
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
February 2006
Actual (reported)
First Submitted
November 7, 2007
Actual (reported)
First Posted
November 8, 2007
Actual (reported)

Last Updated: September 30, 2009
Status Verified: September 2009
Last Update Submitted: September 29, 2009

Conditions

Basal Cell Nevus Syndrome Skin Cancer Xeroderma Pigmentosum

Keywords

PhotoprotectionSunscreenAfter-sun-lotionDNA repair enzymesliposomesskin cancerXeroderma pigmentosumBasal cell nevus syndrome

Outcome Measures

Primary Outcomes (1)

Number of skin cancers
retrospective

Secondary Outcomes (1)

Patients' skin score parameters (including smoothness, color spots, wrinkles, burning, irritation, teleangiectasia, infections, warts, and skin lesions or sores)
retrospective

Eligibility Criteria

Age19 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Primary care clinic

You may qualify if:

Xeroderma pigmentosum

Sponsors & Collaborators

Medical University of Graz
Otherlead

Study Sites (1)

Medical University of Graz, Department of Dermatology

Graz, A-8036, Austria

MeSH Terms

Conditions

Skin NeoplasmsXeroderma PigmentosumBasal Cell Nevus Syndrome

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsSkin DiseasesSkin and Connective Tissue DiseasesPrecancerous ConditionsSkin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticGenetic Diseases, InbornPhotosensitivity DisordersPigmentation Disorders

Study Officials

Peter Wolf, MD
Medical University of Graz
PRINCIPAL INVESTIGATOR

Enrollment

13 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Sponsor Type: OTHER

Study Record Dates

First Submitted

November 7, 2007

First Posted

November 8, 2007

Study Start

October 2004

Date type not reported

This date has not been verified as actual or estimated.

The Impact of Total Body Skin Examination on Skin Cancer Detection

Not ApplicableCompleted

NCT00054691

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

Phase 2Completed

NCT00193895

Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck

Phase 3Completed

NCT00367042

Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks

Phase 2/3Completed

NCT00894855

Skin Cancer Screening and Education at Beaches

Not ApplicableCompleted

NCT00432471

Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers

Not ApplicableCompleted

Basal cell nevus syndrome

Other patient with a history of multiple skin cancers (three or more lesions, including actinic keratosis, squamous cell carcinoma, basal cell carcinoma, and/or malignant melanoma)

You may not qualify if:

Intolerance of study preparation
Allergy against study preparation
Non-acceptable side effects

Contact the study team to confirm eligibility.

DNA Repair-Deficiency Disorders

Metabolic Diseases

Nutritional and Metabolic Diseases

Odontogenic Cysts

Jaw Cysts

Bone Cysts

Cysts

Carcinoma, Basal Cell

Carcinoma

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Neoplasms, Basal Cell

Neoplastic Syndromes, Hereditary

Bone Diseases, Developmental

Bone Diseases

Musculoskeletal Diseases

Jaw Diseases

Stomatognathic Diseases

Abnormalities, Multiple

Study Completion

February 2006

Actual (reported)

Last Updated

September 30, 2009

Record last verified: 2009-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00555633
Data provider: ClinicalTrials.gov
Source updated: 2009-09-30
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:22:14 UTC

Locations

AT(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations